SYF

Synchrony is a private-label/co-brand credit card lender (CareCredit, Dual Card, partner programs) earning a 21.2% return on equity yet priced at just 8.4x FY2025 diluted EPS of $9.28. That valuation gap is the core of the bull case: the market is pricing in a consumer-credit downturn, but the current numbers show a profitable, well-capitalized balance sheet — $16.8B equity, $15.0B cash, retained earnings up 13.7% — funding heavy capital return rather than distress.

The quality of the earnings growth deserves a clear eye: net income was essentially flat (+1.5% to $3.55B) and operating cash flow was unchanged at $9.85B, so almost all of the +8.5% EPS growth came from a 10.6% reduction in shares outstanding. Buybacks nearly tripled to $2.94B (+191.8%). That is fine — it is the right use of capital when the stock trades below ~1.6x book — but investors should understand they are buying a steady, lightly-growing earnings stream that is being concentrated into fewer shares, not an accelerating business. The four-year net-income path ($4.22B → $3.02B → $2.24B → $3.50B → $3.55B) confirms the cyclicality: the 2022-23 trough reflected credit-loss normalization, and earnings have since recovered without yet reclaiming the 2021 peak.